Seven Eight Capital, LP Emergent Bio Solutions Inc. Transaction History

Seven Eight Capital, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$49.34 - $68.76 $601,948 - $838,872	-12,200 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$51.21 - $59.06 $394,317 - $454,762	7,700 Added 171.11%	12,200 $658,000
Q3 2019 Nov 14, 2019	BUY	$40.6 - $57.2 $182,700 - $257,400	4,500 New	4,500 $235,000
Q2 2019 Aug 12, 2019	SELL	$39.92 - $53.86 $311,376 - $420,108	-7,800 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$48.23 - $66.16 $144,690 - $198,480	-3,000 Reduced 27.78%	7,800 $394,000
Q4 2018 Feb 14, 2019	BUY	$55.63 - $73.24 $600,804 - $790,992	10,800 New	10,800 $640,000
Q2 2018 Aug 07, 2018	SELL	$48.33 - $55.64 $642,789 - $740,012	-13,300 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$44.44 - $54.39 $591,052 - $723,387	13,300 New	13,300 $700,000

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $500M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.